The first experimental gene
therapy to treat a patient affected by serious haemophilia A has
been completed in Milan, sources said Thursday.
At Milan's Policlinico Hospital, in fact, "the first patient
was treated at the start of November, and today after almost
four weeks from the infusion he is in good conditions and is
leading a regular life," they said.
The therapy will enable him to avoid the frequent infusions
which he had to received up till now, and to have a coagulation
of the blood equal to that of any normal person.
ALL RIGHTS RESERVED © Copyright ANSA